Trial intelligence / Profile preview

Iron with or without folic acid for postpartum anemia

NL-OMON25164Phase 3Not yet recruiting

Sponsor
TweeSteden Ziekenhuis
Start
Mar 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of ferrous fumarate and folic acid in postpartum anemia (3 arms), sponsored by TweeSteden Ziekenhuis. Primary endpoint: Increase in hemoglobin. Planned start Mar 2008; status: not yet recruiting.

02

Drugs

ferrous fumaratefolic acid
03

Conditions

postpartum anemia

Beyond the preview

Go deeper on NL-OMON25164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call